BTK Degraders in CLL/SLL After BTK Inhibitor Failure: A Promising Escape Route Still Under Study Review Abstract Purpose: This review assesses the rationale, emerging clinical evidence, safety considerations, and practical implications of Bruton tyrosine kinase (BTK) degraders in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), particularly after
Tag: Targeted therapy
Topical vs Systemic Therapy in Psoriasis: Escalating Wisely in the Biologic Era
Topical vs Systemic Therapy in Psoriasis: Escalating Wisely in the Biologic Era Review Abstract Purpose: This review examines how clinicians should decide among optimized topical therapy, phototherapy, oral systemic treatment, and biologic therapy in plaque psoriasis. Methodology: Review of recent clinical guidelines, FDA prescribing information,
FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment
FDA-Approved ADCs: Breaking New Ground in Breast, Lung, and Gastric Cancer Treatment Check out our extensive video library (see channel for our latest videos) Introduction FDA-approved ADCs are revolutionizing cancer treatment landscapes, as the fifth most prevalent malignancy globally, gastric cancer ranks
Targeted Therapy vs. Immunotherapy in Oncology: Advancements and Comparisons Since 2022
Targeted Therapy vs. Immunotherapy in Oncology: Advancements and Comparisons Since 2022 Abstract This paper analyzes the recent developments in targeted therapy and immunotherapy for cancer treatment, focusing on advancements made since 2022. It compares these two approaches by examining their mechanisms, effectiveness, and potential applications across
